Nox4 as a novel target to treat diabetic nephropathy — ASN Events

Nox4 as a novel target to treat diabetic nephropathy (#90)

Karin AM Jandeleit-Dahm 1 2 , Jay C Jha 1 2 , Stephen P Gray 1 , Cedric Szyndralewiez 3 , Freddy Heitz 3 , Mark E Cooper 1 , Kirstin Wingler 4 , Harald HHW Schmidt 4
  1. Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia
  2. Department of Medicine, Monash University, Melbourne, Victoria, Australia
  3. Genkyotex SA, Geneva, Switzerland
  4. Cardiovascular Research Institute Maastricht; Faculty of Medicine, Health & Life Science, Maastricht University, Maastricht, Netherlands
Publish consent withheld
@ADSADEA